Hi-Tech Pharmaceuticals
Hi-Tech Pharmaceuticals, a leading name in the dietary supplement industry, is headquartered in the United States. Founded in 1994, the company has established itself as a pioneer in the development of innovative nutritional products, focusing on weight loss, energy enhancement, and overall wellness. With a commitment to quality and efficacy, Hi-Tech Pharmaceuticals offers a diverse range of core products, including advanced fat burners and pre-workout supplements, distinguished by their scientifically-backed formulations. Operating primarily in the US market, Hi-Tech Pharmaceuticals has achieved notable milestones, including the introduction of several award-winning products that have garnered a loyal customer base. The company’s dedication to research and development, combined with its robust manufacturing capabilities, positions it as a formidable player in the competitive health and wellness sector.
DitchCarbon Score
How does Hi-Tech Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hi-Tech Pharmaceuticals's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hi-Tech Pharmaceuticals's reported carbon emissions
Hi-Tech Pharmaceuticals, headquartered in the US, currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of detailed emissions data, it is important to note that Hi-Tech Pharmaceuticals has not outlined any specific reduction targets or commitments to climate initiatives. This lack of information suggests that the company may not have formalised its climate strategy or set measurable goals for reducing its carbon footprint. As the industry increasingly prioritises sustainability and climate action, it will be essential for Hi-Tech Pharmaceuticals to consider establishing clear climate commitments and reduction targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hi-Tech Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
